Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Direct to Consumer Communication in the Pharmaceutical Industry The Royalty Rate Report 2010: A Comprehensive Assessment of ... Supply Chain in the Pharmaceutical Industry The Biochemistry of Drug Metabolism: Two Volume Set      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing a category Home  - Pharmaceuticals   Companies Drug Delivery Markets OTC Respiratory Vitamins Drug Discovery Technology E-Healthcare Central Nervous System Generics Genomics Immune Disorders Infectious Diseases Oncology Pharmacoeconomics Women's Health Cardiovascular Fast Facts Analgesics   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC   Sorted by Date Added Generics in Japan Biopharm Knowledge Publishing, Nov 2009 The largest untapped market for generics and biosimilars Japan is the second largest pharmaceutical market in the world But only 5% of the market, by value, is taken by generic drugs Like other major ... Generic and Innovative Drugs Markets in Central and Eastern Europe 2009 PMR Ltd, Nov 2009, Pages: 281 Generic and innovative drugs markets in Central and Eastern Europe 2009 - Comparative analysis, reimbursement policies and development forecasts 2009-2011 This report provides a study analysis of the ... Optimizing Lifecycle Management: Maximizing Commercial Lifespan Through Label Expansion and Combination Products Business Insights, Oct 2009, Pages: 112 The need to derive the maximum commercial mileage from all components of a drug company’s portfolio is clearly evident in an era of falling returns on investment and higher capital costs This report i... Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook Business Insights, Oct 2009, Pages: 141 Despite public policy measures to prevent cancer, such as tobacco control and vaccination against HPV, cancer is sure to remain a significant public health problem throughout the 21st century Indeed, ... The CMO Market Outlook: Emerging Markets, Key Players and Future Trends Business Monitor International, Oct 2009, Pages: 98 Falling productivity and patent expiries are placing increasing pressure on pharmaceutical companies to reduce fix costs including large manufacturing facilities Sponsors are turning to CMOs in search... Competitor Analysis: CXCR and CXCL Agonists and Antagonists La Merie, Nov 2009, Pages: 30 The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor CXCR or its ligands CXCL targeting molecul... Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors La Merie, Nov 2009, Pages: 22 The present Competitive Intelligence Report about Heat shock protein 90 (Hsp90) Inhibitors provides a competitor evaluation in the field of novel small molecules and antibodies targeting the heat shoc... Substance Abuse Treatment for Youth and Adults: Clinician's Guide to Evidence-Based Practice John Wiley and Sons Ltd, Sep 2009, Pages: 432 State-of-the-art, empirical support for the treatment of substance abuse Part of the Clinician's Guide to Evidence-Based Practice Series, Substance Abuse Treatment for Youth and Adults provides busy m... The Sugar Code: Fundamentals of Glycosciences John Wiley and Sons Ltd, Sep 2009, Pages: 597 A reader friendly, strategically structured introduction to glycosciences, guiding from the basics of the sugar alphabet and pertinent aspects of chemical/natural glycosylation to functional carbohydr... Global Stem Cell and Advanced Technologies Market MarketsandMarkets.com, Nov 2009, Pages: 229 The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies The benefits of stem cell therapy are attracting an increasing number of patients The product... Opportunity Analysis of H1N1 (swine flu) Vaccination Market MarketsandMarkets.com, Nov 2009, Pages: 126 H1N1 Influenza A (2009) is the first pandemic influenza of 21st century affecting more than more than four lac people in more than 180 countries across the globe in 2009 The flu broke in Mexico in the... China Pharma Outsourcing Annual Review 2009 JZMed Inc., Nov 2009, Pages: 162 It has been well recognized that 2009 is a rough year to all types of industries worldwide The financial crisis has significantly altered both pharmaceutical and biotechnology industries on global sca... Hypertension: Treatments and Prescribing Practices - A Global Survey BioPharm Reports (VennBio Ltd.), Nov 2009, Pages: 225 This report presents the findings of a global survey on current treatments and prescribing practices for Hypertension These findings were made following the participation of more than 280 clinics worl... Nigeria Pharmaceuticals and Healthcare Report Q1 2010 Business Monitor International, Nov 2009, Pages: 90 Nigeria Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with indepe... Neurological Disease: Early-Stage R&D and Dealmaking Decision Resources, Inc., Aug 2009, Pages: 25 How can early-stage R&D efforts be positioned to tap the remaining opportunity in the neurology drug market? Although brimming with potential, neurology drug development is also rife with unique chall... Kenya Pharmaceuticals and Healthcare Report Q1 2010 Business Monitor International, Nov 2009, Pages: 73 Kenya Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independ... Strategies for Building Early-Stage Pharmaceutical Pipelines Through External Sources Decision Resources, Inc., July 2009, Pages: 29 Under tremendous pressure to refuel dwindling development pipelines and improve R&D productivity, pharmaceutical companies are seeking external sources of products and innovation Biotech companies off... Argentina Pharmaceuticals and Healthcare Report Q1 2010 Business Monitor International, Nov 2009, Pages: 89 Argentina Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with inde... Poland Pharmaceuticals and Healthcare Report Q1 2010 Business Monitor International, Nov 2009, Pages: 82 Poland Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with indepen... Pharmaceutical Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009 Decision Resources, Inc., Oct 2009, Pages: 40 The third quarter of 2009 saw a heated debate in the United States over healthcare reform, the publication of a report on a European investigation of the pharmaceutical industry, the election of new g... Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		Top of page

All rights reserved. © Copyright 2009 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster